Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Therapeutic Targeting of Mertk and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia

Ryan J Summers, Juhi Jain, Eleana Vasileiadi, Brittany Smith, Madison Stout, James Kelvin, Xiaodong Wang, Stephen V Frye, H. Shelton Earp, Jeffrey W. Tyner, Erik Dreaden, Deborah DeRyckere, Douglas K Graham

Blood (2021) 138 (Supplement 1): 1184.

https://doi.org/10.1182/blood-2021-151726

Published: 2021

Journal Articles

Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis

Alisa Lee-Sherick, MD, Kristen Jacobsen, PhD, Curtis J. Henry, PhD, Rebecca Parker, Xiaodong Wang, PhD, Stephen V Frye, PhD, H. Shelton Earp, MD, Deborah DeRyckere, PhD, Douglas K Graham, MD PhD

Blood (2018) 132 (Supplement 1): 4019.

https://doi.org/10.1182/blood-2018-99-119818

Published: 2018

Journal Articles

Mertk Is a Therapeutic Target in Early T-Precursor Acute Lymphoblastic Leukemia

Ryan J Summers, MD, Katherine A Minson, MD, Stephen V Frye, PhD, Xiaodong Wang, PhD, H. Shelton Earp, III, MD, Deborah DeRyckere, PhD, Douglas K. Graham, MD PhD

Blood (2017) 130 (Supplement 1): 2536.

https://doi.org/10.1182/blood.V130.Suppl_1.2536.2536

Published: 2017

Journal Articles

Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Myeloid Leukemia

Katherine A Minson, MD, Madeline G Huey, BA, Annie Qiu, Xiaodong Wang, PhD, Stephen V Frye, PhD, H. Shelton Earp, MD, Deborah DeRyckere, PhD, Douglas K Graham, MD PhD

Blood (2017) 130 (Supplement 1): 3823.

https://doi.org/10.1182/blood.V130.Suppl_1.3823.3823

Published: 2017

Journal Articles

Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia

Katherine A Minson, MD, Madeline G Huey, BS, Amanda A Hill, Irene Perez, Xiaodong Wang, PhD, Stephen Frye, PhD, H. Shelton Earp, III, MD, Deborah DeRyckere, PhD, Douglas K. Graham, MD PhD

Blood (2016) 128 (22): 2819.

https://doi.org/10.1182/blood.V128.22.2819.2819

Published: 2016

Journal Articles

MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia

Lauren Shelby Page, BS, Xiaodong Wang, PhD, H. Shelton Earp, III, MD, Stephen Frye, PhD, Craig T Jordan, PhD, Alisa B. Lee-Sherick, MD

Blood (2016) 128 (22): 4044.

https://doi.org/10.1182/blood.V128.22.4044.4044

Published: 2016

Journal Articles

UNC2025, a Small Molecule MerTK and Flt3 Tyrosine Kinase Inhibitor, Decreases Disease Burden, Prolongs Survival, and Promotes Sensitivity to Chemotherapy in Xenograft Models of Acute Leukemia

Deborah DeRyckere, PhD, Alisa B. Lee-Sherick, MD, Amanda A. Hill, Lauren Page, BS, Xiaodong Wang, PhD, Stephen V. Frye, PhD, H. Shelton Earp, MD, Douglas K. Graham, MD PhD

Blood (2014) 124 (21): 998.

https://doi.org/10.1182/blood.V124.21.998.998

Published: 2014

Journal Articles

MRX2843, a Novel Dual MerTK-FLT3 Inhibitor with Activity Against Resistance-Conferring FLT3 Mutations in Acute Myeloid Leukemia

Katherine A Minson, MD, Catherine C Smith, MD, Alisa B. Lee-Sherick, MD, Deborah DeRyckere, PhD, Elisabeth Lasater, PhD, Amanda A. Hill, Xiaodong Wang, PhD, Stephen V. Frye, PhD, H. Shelton Earp, MD, Neil P. Shah, MD PhD, Douglas K. Graham, MD PhD

Blood (2014) 124 (21): 3757.

https://doi.org/10.1182/blood.V124.21.3757.3757

Published: 2014

Journal Articles

Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma

Sandra Christoph, Silke Maag, Deborah DeRyckere, Douglas K. Graham, MD, PhD, Stephen V Frye, H. Shelton Earp, III, Jing Liu, Chao Yang, Weihe Zhang, Xiaodong Wang, Ahmet H. Elmaagacli, Dietrich Beelen, MD

Blood (2013) 122 (21): 1957.

https://doi.org/10.1182/blood.V122.21.1957.1957

Published: 2013

Journal Articles

Development Of a Novel Small Molecule Inhibitor Of The Mer Tyrosine Kinase For Treatment Of Acute Lymphoblastic Leukemia

Deborah DeRyckere, Xiaodong Wang, Amanda A Hill, Weihe Zhang, Michael A Stashko, Susan Sather, Christopher E Cummings, William P Janzen, Stephen V Frye, H. Shelton Earp, III, Douglas K. Graham, MD, PhD

Blood (2013) 122 (21): 2666.

https://doi.org/10.1182/blood.V122.21.2666.2666

Published: 2013

Journal Articles

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Mediate Synergistic Inhibition Of Platelet Aggregation In Combination With ADP/P2Y Antagonists

Gilbert Acevedo, BS, Brian R. Branchford, MD, Luke Law, BS, Christine Brzezinski, Susan Sather, Gary Brodsky, PhD, Deborah DeRyckere, Ph.D., Weihe Zhang, H. Shelton Earp, III, Stephen V Frye, Douglas K. Graham, MD, PhD, Jorge Di Paola, MD

Blood (2013) 122 (21): 3507.

https://doi.org/10.1182/blood.V122.21.3507.3507

Published: 2013

Journal Articles

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Inhibit Platelet Aggregation In Vitro and Protect Mice From Arterial and Venous Thrombosis In Vivo

Gilbert Acevedo, BS, Brian R. Branchford, MD, Christine Brzezinski, Susan Sather, Gary Brodsky, PhD, Deborah DeRyckere, Ph.D., Weihe Zhang, Jing Liu, H. Shelton Earp, III, Xiaodong Wang, Stephen V Frye, Douglas K. Graham, MD, PhD, Jorge Di Paola, MD

Blood (2013) 122 (21): 2296.

https://doi.org/10.1182/blood.V122.21.2296.2296

Published: 2013

Journal Articles

UNC1666, a Dual Mer and Flt-3 Tyrosine Kinase Small Molecule Inhibitor In Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Amanda A Hill, Sean Rinella, MPH, Jing Liu, Deborah DeRyckere, Xiaodong Wang, Stephen V Frye, H. Shelton Earp, III, Douglas K. Graham, MD, PhD

Blood (2013) 122 (21): 3849.

https://doi.org/10.1182/blood.V122.21.3849.3849

Published: 2013

Journal Articles

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

Rachel M. A. Linger, Alisa B. Lee-Sherick, Deborah DeRyckere, Rebecca A. Cohen, Kristen M. Jacobsen, Amy McGranahan, Luis N. Brandão, Amanda Winges, Kelly K. Sawczyn, Xiayuan Liang, Amy K. Keating, Aik Choon Tan, H. Shelton Earp, Douglas K. Graham

Blood (2013) 122 (9): 1599–1609.

https://doi.org/10.1182/blood-2013-01-478156

Published: 2013

Includes: Supplemental data

Journal Articles

A Small Molecule Inhibitor of the Gas6/Mer Pathway Inhibits Platelet Activation and Thrombosis with Equal Efficacy to, but Greater Potency Than, iMer, the Novel MerTK Splice Variant

Brian R. Branchford, MD, Luke Law, BS, Susan Sather, BS, Gary Brodsky, PhD, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Douglas K. Graham, MD, PhD, Jorge A Di Paola, MD

Blood (2012) 120 (21): 3303.

https://doi.org/10.1182/blood.V120.21.3303.3303

Published: 2012

Journal Articles

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Alisa B. Lee-Sherick, MD, Kelly Menachof, Kristen M. Eisenman, MD, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, PhD, Jennifer Schlegel, Paul M Armistead, MD, PhD, Xiayuan Liang, MD, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, III, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, PhD, Douglas K. Graham, MD, PhD

Blood (2012) 120 (21): 1317.

https://doi.org/10.1182/blood.V120.21.1317.1317

Published: 2012

Journal Articles

Evaluation of UNC569, a Novel Small Molecule Mer Inhibitor for the Treatment of ALL in Vitro and in Vivo.

Sandra Christoph, Deborah DeRyckere, PhD, Jennifer Schlegel, Susan Sather, BS, Amy McGranahan, J. Kimble Franzer, Alesia Trakhimets, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, III, Gary L. Johnson, Douglas K. Graham

Blood (2012) 120 (21): 2607.

https://doi.org/10.1182/blood.V120.21.2607.2607

Published: 2012

Journal Articles

UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL

Sandra Christoph, Deborah DeRyckere, PhD, Susan Sather, BS, Xiaodong Wang, Dmitri Kireev, William Janzen, Jing Liu, Chao Yang, Amy van Deusen, Catherine Simpson, Jacqueline Norris-Drouin, Stephen Frye, H. Shelton Earp, III, Gary L. Johnson, Douglas K. Graham

Blood (2011) 118 (21): 2589.

https://doi.org/10.1182/blood.V118.21.2589.2589

Published: 2011

Journal Articles

A novel role for c-Src and STAT3 in apoptotic cell–mediated MerTK-dependent immunoregulation of dendritic cells

Zuoan Yi, Li Li, Glenn K. Matsushima, H. Shelton Earp, Bo Wang, Roland Tisch

Blood (2009) 114 (15): 3191–3198.

https://doi.org/10.1182/blood-2009-03-207522

Published: 2009

Includes: Supplemental data

Journal Articles

Disruption of GAS6-MER Pathway Leads to Defects in Physiological Clearance of Expelled Nuclei from Erythroblasts by Bone Marrow Macrophages

Linda Kadi, Laurent Burnier, Rocco Sugamele, Peter Carmeliet, Greg Lemke, H. Shelton Earp, III, Glenn K. Matsushima, Marc Schapira, Anne Angelillo-Scherrer

Blood (2008) 112 (11): 499.

https://doi.org/10.1182/blood.V112.11.499.499

Published: 2008

NARROW

Therapeutic Targeting of Mertk and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia

Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis

Mertk Is a Therapeutic Target in Early T-Precursor Acute Lymphoblastic Leukemia

Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Myeloid Leukemia

Bone Marrow Stromal Cell Mediated Resistance to Mertk Inhibition in Acute Leukemia

MerTK Receptor Tyrosine Kinase Inhibition As a Potential Strategy to Augment Immune-Mediated Clearance of Acute Myeloid Leukemia

UNC2025, a Small Molecule MerTK and Flt3 Tyrosine Kinase Inhibitor, Decreases Disease Burden, Prolongs Survival, and Promotes Sensitivity to Chemotherapy in Xenograft Models of Acute Leukemia

MRX2843, a Novel Dual MerTK-FLT3 Inhibitor with Activity Against Resistance-Conferring FLT3 Mutations in Acute Myeloid Leukemia

Mer Receptor Tyrosine Kinase Is a Novel Therapeutic Target In Multiple Myeloma

Development Of a Novel Small Molecule Inhibitor Of The Mer Tyrosine Kinase For Treatment Of Acute Lymphoblastic Leukemia

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Mediate Synergistic Inhibition Of Platelet Aggregation In Combination With ADP/P2Y Antagonists

Novel Small Molecule Inhibitors Of The Gas6/TAM Signaling Pathway Inhibit Platelet Aggregation In Vitro and Protect Mice From Arterial and Venous Thrombosis In Vivo

UNC1666, a Dual Mer and Flt-3 Tyrosine Kinase Small Molecule Inhibitor In Acute Myeloid Leukemia

Mer receptor tyrosine kinase is a therapeutic target in pre–B-cell acute lymphoblastic leukemia

A Small Molecule Inhibitor of the Gas6/Mer Pathway Inhibits Platelet Activation and Thrombosis with Equal Efficacy to, but Greater Potency Than, iMer, the Novel MerTK Splice Variant

Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia

Evaluation of UNC569, a Novel Small Molecule Mer Inhibitor for the Treatment of ALL in Vitro and in Vivo.

UNC569 As Novel Small Molecule Mer Receptor Tyrosine Kinase Inhibitor for Treatment of ALL

A novel role for c-Src and STAT3 in apoptotic cell–mediated MerTK-dependent immunoregulation of dendritic cells

Disruption of GAS6-MER Pathway Leads to Defects in Physiological Clearance of Expelled Nuclei from Erythroblasts by Bone Marrow Macrophages

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only